URL has been copied successfully!
U.S. employers are preparing for rising healthcare costs next year, which could lead to reduced coverage of popular GLP-1 weight-loss drugs.
According to an Aug. 25 Business Group on Health’s 2027 Employer Healthcare Strategy Survey, employers are predicting a median 9.2 percent hike in healthcare costs for 2027. The report indicates that the projected cost growth could be reduced to about 8 percent through changes to employee benefit plans and other cost-mitigation strategies.
Employers expect a median cost growth of 8.5 percent for 2026, with a possible reduction to 7 percent after healthcare plan alterations.
Employers surveyed reported that pharmacy costs make up about 25 percent of healthcare spending and are projected to increase by 12 percent in 2026, driven in part by the rapid growth in GLP-1 medications….
According to an Aug. 25 Business Group on Health’s 2027 Employer Healthcare Strategy Survey, employers are predicting a median 9.2 percent hike in healthcare costs for 2027. The report indicates that the projected cost growth could be reduced to about 8 percent through changes to employee benefit plans and other cost-mitigation strategies.
Employers expect a median cost growth of 8.5 percent for 2026, with a possible reduction to 7 percent after healthcare plan alterations.
Employers surveyed reported that pharmacy costs make up about 25 percent of healthcare spending and are projected to increase by 12 percent in 2026, driven in part by the rapid growth in GLP-1 medications….
Please follow us:
